[1] Fujii Y, Tanaka H.Comparison of granisetron and ramosetron for the prevention of nausea and vomiting after thyroidectomy[J]. Clin Ther, 2002,24(5):766-772. [2] Kovac A L.Prevention and treatment of postoperative nausea and vomiting[J]. Drugs, 2005,62(12) :1261-1262. [3] Williams K S.Postoperative nausea and vomiting[J]. Surg Clin North Am, 2005,85(6):1229-1241. [4] Gold B,Kitz D S, Lecky J H.Unanticipated admission to the hospital following ambulatory surger[J]. FAMA, 1989,262(21):3008-3010. [5] Kim S I, Kim S C, Baek Y H,et al.Comparison of ramosetron with ondansetron for prevention of postoperative nausea and vomiting in patients undergoing gynaecological surgery[J]. Br J Anaesth, 2009,103(4):549-553. [6] Kvles P S, Williams D L, Hendrta M, et al.Patien sarisfaction after anesthesia and surgery: Results of a prospective survey of 10811 patients[J]. Br F Anaesth, 2000,84(1):6-10. [7] Akin A,Esmaoglu A,Gunes I,et al.The effects of the prophylactic tropisetron-propofol combination on postoperative nausea and vomiting in patients undergoing thyroidectomy under desflurane anesthesia[J]. Mt Sinai J Med, 2006,73(2):560-563. [8] 赵翠红, 张汉湘,王盛海,等. 手术麻醉患者预防性使用 5-HT3 受体拮抗剂临床应用研究[J].中国药物警戒, 2016,13(10):587. [9] Lovstad R Z, Thagaard K S, Berner N S, et al.Neostigmine 50microg kg(-1) with glycopyrrolate increases postoperative nau-sea in women after laparoscopic gynaecological surgery[J].Acta-Anaesthesiol Scand, 2001,45(4):495-500. [10] Mutlu T, Hanc1 V. Comparison of the effects of sugammadex and neostigmine on postoperative nausea and vomiting[J]. Bars J of Anesthesiology, 2016,67(2):147-152. [11] Alfieri A B, Cebeddu L X.Treatment with para-chlorophenylalanine antagonises the emetic response and the serotoninreleasing actions of cisplatin in cancer patients[J]. Br J Cancer, 1995,71(3): 629-632. [12] Leslie R A, Shah Y, Thejomayen M, et al.The neuropharmacology of emesis: the role of receptors in neuromodulation of nausea and vomiting[J]. Can J Physiol Pharmacol, 1990, 68(2):279-288. [13] Constenla M.5-HT3 receptor antagonists for prevention of late acute-onset emesis[J]. Ann Pharmacother, 2004,38(10):1683-1691. [14] Tricco A C, Soobiah C, Antony J.Interventions to decrease the risk of adverse cardiac events for post-surgery or chemotherapy patients taking serotonin(5-HT3) receptor antagonists: protocol for a systematic review and network meta-analysis[J]. Systematic Reviews, 2013,2(45):1-5. [15] 吕新颜, 梁茂本. 44例5-HT3受体拮抗剂不良反应文献分析[J]. 中国药物警戒, 2013,10(3):167. [16] Yamanaga, Shigeyoshi, Posselt, et al. A Single Perioperative Injection of Dexamethasone Decreases Nausea Vomiting and Pain after Laparoscopic Donor Nephrectomy[J]. Journal of Transplantation, 2017,2017(10):1155. [17] Schwartzberg L, Jackson J,Jain G,et al.Impact of 5-HT3 RA selection within triple antiemetic regimens on uncontrolled highly emetogenic chemotherapy-induced nausea/vomiting[J]. Expert Rea Pharmacoecon Outcomes Res, 2011,11(4):481-488. [18] Baciarello M, Cornini A.Intrathecal atropine to prevent postoperative nausea and vomiting after cesarean section: A randomized, controlled trial[J]. Minerva anestesiologica, 2011, 77(8):781-788. [19] Gregory R E, Ettinger D S.5-HT3 Receptor Antagonists for the Prevention of Chemotherapy-Induced Nausea and Vomiting[J]. Drugs, 1998,55(2):173-189. [20] Jamwal A, Jatindera M,Wakhloo R,et al.Safety profile of various 5HT3 receptor antagonists used for PONV prophylaxis[J]. JK Science, 2016,18(2):111-115. [21] 谭欣. 不同5-HT3 受体拮抗剂预防腹腔镜术后恶心呕吐的临床观察[J]. 比较哲学, 2014,11(35):345. |